Consistent with the oncogenic role of TP63 in SCC, genes positively correlated with TP63 expression were enriched in cancer-promoting hallmark pathways, including E2F targets, G2M checkpoint, MYC targets and mTOR signaling pathways (Supplementary Fig. 1B). The gene discussed is MTOR; the disease is cancer.